MarketInOut Stock Screener Log In | Sign Up

Scilex Holding Co Wt

NASDAQ • Healthcare • Drug Manufacturers - General • Quote as of 10/29/2026 11:30
Scilex Holding Co Wt stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNASDAQ
Market Capitalization34.39 mln
Float5.69 mln
Earnings Date11/13/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-9.08
Highly reliable

Relative Strength

0 / 100
Severely lagging

Pre-Tax Margin

-1,470%
Severely loss-making

ROE

190
Extraordinary

Altman Z-Score

-13.89
Deeply distressed

Business Description

Scilex Holding Company is a Palo Alto-based healthcare company focused entirely on treating acute and chronic pain without the use of opioids. Its three marketed products address nerve pain from shingles, migraines, and gout flares, while its pipeline includes a gel injection for sciatica, a stronger lidocaine patch for neck and back pain, and a low-dose capsule for fibromyalgia. The company works with partners in Japan and the United States to manufacture and develop its treatments.

Key Fundamentals

EPS-64.88
ROE190
RPS3.64
ROIC-93.59
ROA-176
Interest Cover-17.65
EBITDA, mln-277
EV / EBITDA-0.31
Revenue, mln31.61

Quote Details

Last 0.0391
Change -0.0059 (-13.11%)
Open 0.0399
Volume 3,637
Turnover 142.21
Average Volume 7,712.95

Financial Ratios

Pre-Tax Profit Margin-1,470
Current Ratio0.07
Price / Sales1.24

Financial Strength

Altman Z-Score-13.89
Piotroski F-Score 2 / 9
Beneish M-Score-9.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -34.83% 1 / 100   
1 Month -59.69% 2 / 100   
2 Months -67.42% 4 / 100   
6 Months -69.02% 7 / 100   
1 Year -92.76% 5 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog